Urokinase plasminogen activator (uPA) has been associated with invasion and metastasis in breast cancer. The expression of uPA and 92 kDa type IV collagenase (gelatinase B/MMP-9) is regulated by growth factors, receptor-type tyrosine kinases and cytoplasmic oncoproteins. Here, we have identified tra
The notch-responsive transcription factor Hes-1 attenuates osteocalcin promoter activity in osteoblastic cells
✍ Scribed by Ying Zhang; Jane B. Lian; Janet L. Stein; Andre J. van Wijnen; Gary S. Stein
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 302 KB
- Volume
- 108
- Category
- Article
- ISSN
- 0730-2312
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Notch signaling plays a key role in osteoblast differentiation. A major transcriptional downstream regulator of this pathway is the helix–loop–helix (HLH) transcription factor Hairy/Enhancer of Split 1 (Hes‐1). Here we investigated the function of Hes‐1 in osteoblastic cells. Endogenous Hes‐1 gene expression decreases during progression of bone cell phenotype development in MC3T3‐E1 osteoblasts suggesting that it is a negative regulator of osteoblast differentiation. Forced expression of Hes‐1 inhibits osteocalcin (OC) mRNA levels, and luciferase assays indicate that Hes‐1 directly represses OC promoter activity. In vitro and in vivo protein/DNA interaction assays reveal that recombinant Hes‐1 binds specifically to an E‐box in the proximal promoter of the OC gene. Deletion of the Hes‐1 WRPW domain (MHes‐1) that recruits the co‐repressor Groucho abrogates repression of OC promoter activity by Hes‐1, but also blocks Hes‐1 binding to the promoter. The latter result suggests that exogenous Hes‐1 may be recruited to the OC promoter by both protein/DNA and protein/protein interactions. We conclude that the Notch‐responsive Hes‐1 protein is capable of repressing OC gene transcription in osteoblastic cells through an E‐box in the proximal promoter. Hes‐1 may contribute to osteoblast growth and differentiation by controlling basal bone‐specific transcription directly through interactions with transcriptional regulators that are known to bind to the OC gene promoter. J. Cell. Biochem. 108: 651–659, 2009. © 2009 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract Receptor activator of nuclear factor kappa B ligand (RANKL), a potent regulator of osteoclast formation and function, is expressed by osteoblasts and bone marrow stromal cells. However, the molecular mechanism underlying RANKL expression in osteoblast/stromal cells remains largely uncle